XPC and colonic neoplasm: To validate this result, we abrogated XPC function by CRISPR/Cas9 in nine other colon cancer cell lines, namely HT-29, HCT-15, RKO, COLO205, LoVo, HCT116, Caco2, SW480 and SW620.